Literature DB >> 21863271

Fulminant multiple sclerosis (MS).

Mohammad Rohani1, Shadi Ghourchian.   

Abstract

Fulminant multiple sclerosis (MS) is the most malignant form of MS which usually leads to death in few weeks. Although it can be accompanied by optic neuritis (ON), but long interval between ON and the grave onset has not been reported. Fulminant MS usually occurs as the first onset and previous ON is not common. We report a rare case of 30-year-old woman with a history of ON 1 year ago. The rapid deterioration to vegetative state followed by a seizure and previous ON differentiated this case from previous reported cases. The differential diagnosis of a rapidly progressive leucoencephalopathy in this patient includes inflammatory, vascular, infectious and toxic disorders. Regarding the previous history of optic neuritis with positive brain MRI (multiple T2 hyperintense lesions in white matter) in our patient, multiple sclerosis is the most probable diagnosis. More effective treatments, such as plasmapheresis and cyclophosphamide, that influenced on the prognosis of some previous patients could be useful, but should be performed before progressive brain atrophy emerges.

Entities:  

Mesh:

Year:  2011        PMID: 21863271     DOI: 10.1007/s10072-011-0723-0

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  30 in total

1.  The pathogenesis of multiple sclerosis: a commentary.

Authors:  C M Poser
Journal:  Clin Neurol Neurosurg       Date:  2000-12       Impact factor: 1.876

2.  Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group.

Authors:  L D Jacobs; R W Beck; J H Simon; R P Kinkel; C M Brownscheidle; T J Murray; N A Simonian; P J Slasor; A W Sandrock
Journal:  N Engl J Med       Date:  2000-09-28       Impact factor: 91.245

3.  Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children.

Authors:  R C Dale; C de Sousa; W K Chong; T C Cox; B Harding; B G Neville
Journal:  Brain       Date:  2000-12       Impact factor: 13.501

Review 4.  Acute disseminated encephalomyelitis.

Authors:  Enrico Marchioni; Eleonora Tavazzi; Lorenzo Minoli; Serena Del Bue; Pasquale Ferrante; Giovanni Piccolo; Stefano Bastianello; Sabrina Ravaglia
Journal:  Neurol Sci       Date:  2008-09       Impact factor: 3.307

5.  Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis.

Authors:  F D Lublin; S C Reingold
Journal:  Neurology       Date:  1996-04       Impact factor: 9.910

6.  Acute multiple sclerosis (Marburg type) is associated with developmentally immature myelin basic protein.

Authors:  D D Wood; J M Bilbao; P O'Connors; M A Moscarello
Journal:  Ann Neurol       Date:  1996-07       Impact factor: 10.422

7.  Treatment of Marburg variant multiple sclerosis with mitoxantrone.

Authors:  Douglas R Jeffery; David S Lefkowitz; Jeffrey P Crittenden
Journal:  J Neuroimaging       Date:  2004-01       Impact factor: 2.486

8.  Malignant monophasic multiple sclerosis or "Marburg's disease".

Authors:  M F Mendez; S Pogacar
Journal:  Neurology       Date:  1988-07       Impact factor: 9.910

9.  Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes.

Authors:  L Kappos; C H Polman; M S Freedman; G Edan; H P Hartung; D H Miller; X Montalban; F Barkhof; L Bauer; P Jakobs; C Pohl; R Sandbrink
Journal:  Neurology       Date:  2006-08-16       Impact factor: 9.910

10.  Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

Authors:  W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

View more
  1 in total

Review 1.  Unprovoked seizures in multiple sclerosis: Why are they rare?

Authors:  Anamarija Kavčič; Werner E Hofmann
Journal:  Brain Behav       Date:  2017-05-24       Impact factor: 2.708

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.